Delivery Order SPE2DB20D1110-SPE2DB25FK30G
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,684.94 by the Defense Logistics Agency (DLA) on July 30, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 31, 2025. The contract represents a child delivery order under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $62,937.18 delivery order from the Defense Logistics Agency (DLA) for 90 tablets of Jardiance 25 mg on July 22, 2025, with an ultimate completion date of July 23, 2025. The award was made under firm fixed-price terms with no set-aside designation, indicating it was competitively awarded. This delivery order is issued as a child contract under AmerisourceBergen's substantial...
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $2,942.21 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA) to supply 4561759437 units of the Jardiance 25 mg tablet. Place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania, with delivery required between August 9-10, 2023. No subcontractors or set aside designations were identified. This order is likely placed against DLA's...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 1, 2025, for the supply of Jardiance 10 mg tablets in a quantity of 90 units, with a ceiling value of $2,348.15. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 4, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- AmerisourceBergen Drug Corp was awarded a delivery order on July 31, 2025, by the Defense Logistics Agency for the supply of Jardiance 10 mg tablets (90-count units) with a contract value of $2,009.06. This is a firm fixed-price delivery order with an ultimate completion date of August 1, 2025, and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is issued...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $17,803.94 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA) to supply 90 tablets of 10 mg Jardiance medication. Performance will take place in Conshohocken, Pennsylvania over one day in September 2023. Jardiance is used to treat type 2 diabetes and help reduce the risk of cardiovascular death in certain patients. This delivery order was issued under DLA's...
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $13,091.59 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply 4562255753, which is Jardiance 25 mg tablets in 90 count packages. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is short, spanning just two days from September 21 to September 22, 2023. No additional details were provided...
- Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, was awarded a $3,684.96 firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical to provide JARDIANCE 25 MG TABLET 90S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for...
- Amerisourcebergen Drug Corporation, under its parent company Amerisourcebergen Corporation, has been awarded a $5,130.40 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA) to supply 90 tablets of 10 mg Jardiance medication. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is short, spanning only August 22 to August 23, 2023. No additional details were provided on the original...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $5,384.32 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA) to provide 90 tablets of 10 mg Jardiance medication. Performance will take place in Conshohocken, Pennsylvania over one day in September 2023. The contract calls for Amerisourcebergen to supply pharmaceutical products to DLA under the agency's Prime Vendor program, which centrally manages the...
- SPE2DB20D1110Indefinite Delivery Contract
- SPE2DB20D1110-SPE2DB25FK30GDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $3,094.36 by the Defense Logistics Agency for the supply of Jardiance 25 mg tablets (90-count packages). The contract, awarded on July 29, 2025, with an ultimate completion date of July 30, 2025, utilizes firm fixed-price pricing and carries no set-aside designation, indicating it was competitively awarded. The place of performance is the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The IDC serves as a comprehensive prime vendor contract enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Jardiance, an oral diabetes medication, falls within the company's extensive portfolio of therapeutic products delivered to Defense Health Agency and other federal healthcare systems through this flexible contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 7/29/25 |